Schedule 13G ownership disclosure

Keros Therapeutics Inc

Common Stock, par value $0.0001 per share · CUSIP: 492327101

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Alkeon Capital Management LLC

    Shares: 1,101,000.00 · Class: 2.7%

  • Panayotis D. Sparaggis

    Shares: 1,101,000.00 · Class: 2.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-001043
Form type
SCHEDULE 13G
Filer
ALKEON CAPITAL MANAGEMENT LLC
CIK
CIK 1230239
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub